Dudediligence.

Heron Therapeutics, Inc

HRTXNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Material agreementSep 29 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: AMPH, AVTX, VTGN→

From the filings

Figures

Revenue
$151.2Mlast 12 months
Net income
−$33.9Mlast 12 months
Operating cash flow
−$20.3Mlast 12 months
Cash and equivalents
$20.7Mat the last balance sheet
Shares outstanding
188.3M shareson issue
Every year and quarter →